KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Enterprise Value (2016 - 2025)

Astrana Health (ASTH) has disclosed Enterprise Value for 16 consecutive years, with -$415.5 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value fell 44.85% to -$415.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$415.5 million through Dec 2025, down 44.85% year-over-year, with the annual reading at -$415.5 million for FY2025, 44.85% down from the prior year.
  • Enterprise Value hit -$415.5 million in Q4 2025 for Astrana Health, up from -$449.9 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$159.0 million in Q1 2021 to a low of -$575.7 million in Q2 2025.
  • Historically, Enterprise Value has averaged -$346.6 million across 5 years, with a median of -$281.6 million in 2022.
  • Biggest five-year swings in Enterprise Value: crashed 279.55% in 2021 and later surged 42.88% in 2024.
  • Year by year, Enterprise Value stood at -$230.0 million in 2021, then fell by 21.47% to -$279.4 million in 2022, then tumbled by 79.77% to -$502.2 million in 2023, then surged by 42.88% to -$286.8 million in 2024, then tumbled by 44.85% to -$415.5 million in 2025.
  • Business Quant data shows Enterprise Value for ASTH at -$415.5 million in Q4 2025, -$449.9 million in Q3 2025, and -$575.7 million in Q2 2025.